Iron scaffold melts away after opening clogged arteries in heart disease trial
NCT ID NCT05205499
First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tests a new device called the Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS) in 1059 people with coronary artery disease. The scaffold props open blocked heart arteries and slowly dissolves over time, releasing a drug to prevent re-blockage. The goal is to see if it is safe and effective at keeping arteries open without needing a permanent metal stent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fuwai Yunnan Cardiovascular Hospital
Kunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.